We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Bionas Raises € 2.1 M to Fund Marketing and Product Expansion

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Bionas GmbH has announced that it closed a € 2.1 million financing deal to fund sales, marketing and product expansion. GENIUS Venture Capital GmbH and the KfW-Bankengruppe (ERP-Startfonds) participated in the financing.

Additionally, the Federal Ministry of Education and Research, Germany (BMBF) and the Federal State of Mecklenburg-Vorpommern (Ministry of Economics) granted subsidies of undisclosed amounts for two development projects.

“The new funding allows us to expand the sales and marketing of Bionas ® analyzing systems throughout Europe and the US,” says Dr. Ralf Ehret, CEO and co-founder of Bionas. “We will also boost technical innovations for novel products and applications to assure the continuous growth of the company.”

The Bionas® 2500 analyzing system, the company´s main product, gives a complete overview of the physiologic state of cells. It can be used to analyze different signal transduction pathways, allowing target validation studies at an early stage in the drug discovery process. Recently, Bionas announced that its device has been selected by Solvay Pharmaceuticals for target validation studies.